United States Antimony Corp (AMEX:UAMY) does about 4.04M shares in volume on a normal day but saw 4766870 shares change hands in the recent trading day. The company now has a market cap of 217.98M USD. Its current market price is $2.01, marking an increase of 9.24% compared to the previous close of $1.84. The 52 week high reached by this stock is $2.35 whilst the lowest price level in 52 weeks is $0.17.
United States Antimony Corp (UAMY) has a 20-day trading average at $1.7600 and the current price is -14.47% off the 52-week high compared with 1060.51% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.6500 and its 200-day simple moving average is $0.7700. If we look at the stock’s price movements over the week, volatility stands at 8.65%, which decreases to 8.55% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 59.95 to suggest the stock is neutral.
The consensus objective for the share price is $2.62, suggesting that the stock has a potential upside of 23.28% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 10, 2024 when H.C. Wainwright initiated the stock to “Buy” and issued a price target of $2.50.
The current price level is 14.27%, 21.50%, and 159.52% away from its SMA20, SMA50, and SMA200 respectively, with the UAMY price moving below the 50-day SMA on current market day. United States Antimony Corp (UAMY) stock is up 19.64% over the week and 35.81% over the past month. Its price is 13.56% year-to-date and 773.15% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year. Expected sales for next quarter are $8.04M, which analysts say will come at $13.87M for the current fiscal year and next year at $40.83M. In addition, estimates put the company’s current quarterly revenue at an average of $4.47M.
To reach the target analysts have set, the stock logically needs to grow 23.28 percent from here.
Outstanding shares total 108.44M with insiders holding 23.71% of the shares and institutional holders owning 18.57% of the company’s common stock. The company has a return on investment of -17.21% and return on equity of -15.54%. The forward price to earnings ratio is 36.55. The beta has a value of 0.62. Price to book ratio is 8.68 and price to sales ratio is 22.40.
